GeoPolitics Pulse

The Heartbeat of World events

Pfizer Inks Up to $6B Deal to Market 3SBio’s Cancer Drug Outside China – Investopedia

by ·

Pfizer has announced a new agreement to develop and market a cancer drug being developed by Chinese drugmaker 3SBio.Read More

Related posts:

  1. Taiwan’s Anbogen inks deal with BeiGene to evaluate combination therapy in colorectal cancer
  2. Merck signs up to $3.3 billion cancer drug deal with China-based LaNova | Reuters
  3. Abbott inks first Lingo retail deal with Amazon – Drug Delivery Business
  4. Applied Materials, Palantir, Tesla, Pfizer, Alibaba, Bloom Energy, and More Market Movers – Barron’s Google Alert – Tesla
  5. Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, and More Market Movers – Barron’s